Resources

The pro-viral DNA capture card maintains the fundamental value provided by dried blood spots (ease of collection and transport from remote settings) while reducing the costs and time of performing pediatric HIV testing in the laboratory. Presented at: AACC 42nd Annual Oak Ridge Conference, April 22, 2010; San Jose, CA.

PATH has demonstrated the use of CaO for heat and a proprietary engineered phase change material (EPCM) to maintain an assay mixture within a narrow temperature range suitable for isothermal amplification. We are currently working to develop, integrate, and validate components of this NAAT kit. Presented at: AACC 42nd Annual Oak Ridge Conference, April 22, 2010; San Jose, CA.

The PATH-Lemos Chagas rapid test has great potential as a highly sensitive diagnostic test for Chagas disease, suitable for use at the point-of-care.  Presented at: AACC 42nd Annual Oak Ridge Conference, April 22, 2010; San Jose, CA.

As part of project Optimize, a five-year human papillomavirus (HPV) vaccine demonstration project is under way in Uganda and three other countries to demonstrate how existing health systems can be adapted to successfully provide HPV vaccine to young adolescent girls. HPV vaccine is a strong candidate for storage and transport in a controlled temperature chain at temperatures higher than the standard 2º to 8ºC cold chain storage.

This report, the first in the Roll Back Malaria Progress & Impact Series, confirms that investment in malaria control is rapidly saving lives and reaping far-reaching benefits for countries. The report demonstrates that without sustained and predictable long-term funding, the significant contribution of malaria control toward achievement of the five Millennium Development Goals that are closely tied to malaria control, as well as progress toward achieving the 2010 Abuja target of universal intervention coverage, could be reversed.